Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-α antagonists

por Fausel, Rebecca, Afzali, Anita
Publicado 2015

Transition of pediatric to adult care in inflammatory bowel disease: Is it as easy as 1, 2, 3?

por Afzali, Anita, Wahbeh, Ghassan
Publicado 2017

Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease

por Chen, Tong, Shi, Ni, Afzali, Anita
Publicado 2019

Indications and safety of newer IBD treatments in the older patient

por Clement, Benjamin, De Felice, Kara, Afzali, Anita
Publicado 2023

Acute Myelogenous Leukemia as a Rare Cause of Duodenal Ulcers

por Sobotka, Lindsay A., Crilley, Tessa, Levine, Edward, Afzali, Anita
Publicado 2019

The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable

por Afzali, Anita, Furtner, Daniel, Melsheimer, Richard, Molloy, Philip J.
Publicado 2021

Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis

por Pusateri, Antoinette, Anaizi, Ahmad, Nemer, Laura, Hinton, Alice, Lara, Luis, Afzali, Anita
Publicado 2022

Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States

por Afzali, Anita, Lukanova, Rina, Hennessy, Fritha, Kakehi, Sumie, Knight, Hannah, Milligan, Gary, Gupte-Singh, Komal
Publicado 2023

Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab

por Chiorean, Michael, Afzali, Anita, Cross, Raymond K, Macaulay, Dendy, Griffith, Jenny, Wang, Anthony, Garcia-Horton, Viviana
Publicado 2020

International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey

por Rubin, David T, Sninsky, Charles, Siegmund, Britta, Sans, Miquel, Hart, Ailsa, Bressler, Brian, Bouhnik, Yoram, Armuzzi, Alessandro, Afzali, Anita
Publicado 2021

A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Con...

por Axelrad, Jordan, Long, Millie, Horst, Sara, Afzali, Anita, Sapir, Tamar, Fajardo, Kristina, De Felice, Kara, Sandler, Robert, Cross, Raymond
Publicado 2022

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

por Clowse, Megan E. B., Scheuerle, Angela E., Chambers, Christina, Afzali, Anita, Kimball, Alexa B., Cush, John J., Cooney, Maureen, Shaughnessy, Laura, Vanderkelen, Mark, Förger, Frauke
Publicado 2018

Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program

por Feagan, Brian G., Schreiber, Stefan, Afzali, Anita, Rieder, Florian, Hyams, Jeffrey, Kollengode, Kanthi, Pearlman, Jared, Son, Vladimir, Marta, Cecilia, Wolf, Douglas C., D'Haens, Geert G.
Publicado 2022

Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring

por Hemperly, Amy, Dubinsky, Marla C, Yarur, Andres, Afzali, Anita, Hanauer, Stephen, Kugathasan, Subra, Long, Millie D, Rabizadeh, Shervin, Sockolow, Robbyn, Okada, Lauren, Jain, Anjali, Abreu, Maria T, Vande Casteele, Niels
Publicado 2021

Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting

por Long, Millie D, Afzali, Anita, Fischer, Monika, Hudesman, David, Abdalla, Maisa, McCabe, Robert, Cohen, Benjamin L, Ungaro, Ryan C, Harlan, Will, Hanson, John, Konijeti, Gauree, Polyak, Steven, Ritter, Timothy, Salzberg, Bruce, Seminerio, Jennifer, English, Emily, Zhang, Xian, Sharma, Puza P, Herfarth, Hans H
Publicado 2022